Issues related to coverage of over-the-counter products with FSAs and HSAs.
2026 · 3rd Quarter (July 1 - Sep 30)
HALEON US HOLDINGS LLC
Filed by CROSSROADS STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- CROSSROADS STRATEGIES, LLC
- Client
- HALEON US HOLDINGS LLC
- Filing UUID
- 3c5549db-d22a-4882-a318-5794c7d1ec5c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Education about the importance of OTC products and benefits under Medicare Advantage.
Policies impacting access to over-the-counter products; FY2027 Financial Services and General Government Appropriations Act (H.R.8495).
Literal federal measure citations: H.R.8495
Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.
Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.